Publications

Pour rechercher une publication scientifique, insérez vos mots-clés en anglais.

Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients.

Abstract

Point-of-care urine-lipoarabinomannan (LAM) Alere Determine TB-LAM assay has shown utility diagnosing tuberculosis (TB) in HIV-positive, severely immunocompromised, TB-symptomatic patients.

Huerga H Cossa L Manhiça I Bastard M Telnov A Molfino L Sanchez-Padilla E
The American journal of tropical medicine and hygiene 2020 Jan 20; doi: 10.4269/ajtmh.19-0493. Epub 2020 01 20

Extended Follow-up From a Randomized Clinical Trial of Routine Amoxicillin in the Treatment of Uncomplicated Severe Acute Malnutrition in Niger.

Abstract

Evidence to support current guidelines recommending routine antibiotic use in the outpatient management of uncomplicated severe acute malnutrition (SAM) is limited and based largely on data from historical inpatient settings.

Isanaka S Grantz KH Berthé F Schaefer M Adehossi E Grais RF
JAMA pediatrics 2020 Jan 13; doi: 10.1001/jamapediatrics.2019.5189. Epub 2020 01 13
Nutrition Amoxicillin

Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi.

Abstract

BACKGROUND: Current eligibility criteria for urine lateral-flow lipoarabinomannan assay (LF-LAM) in ambulatory, HIV-positive patients rely on the CD4 count.

Huerga H Rucker SCM Bastard M Dimba A Kamba C Amoros I Szumilin E
Journal of acquired immune deficiency syndromes (1999) 2020 01 01; 83(1); 24-30. doi: 10.1097/QAI.0000000000002206. Epub 2020 07 06

Feasibility of engaging caregivers in at-home surveillance of children with uncomplicated severe acute malnutrition.

Abstract

Many factors can contribute to low coverage of treatment for severe acute malnutrition (SAM), and a limited number of health facilities and trained personnel can constrain the number of children that receive treatment.

Isanaka S Berthé F Nackers F Tang K Hanson KE Grais RF
Maternal & child nutrition 2020 01 ; 16(1); e12876. doi: 10.1111/mcn.12876. Epub 2019 08 09
MUAC Niger clinical surveillance community-based management of acute malnutrition (CMAM) severe acute malnutrition task shifting

Clinical diagnostic evaluation of HRP2 and pLDH-based rapid diagnostic tests for malaria in an area receiving seasonal malaria chemoprevention in Niger.

Abstract

BACKGROUND: Rapid diagnostic tests (RDT) for malaria are common, but their performance varies. Tests using histidine-rich protein 2 (HRP2) antigen are most common, and many have high sensitivity.

Coldiron ME Assao B Langendorf C Sayinzoga-Makombe N Ciglenecki I de la Tour R Piriou E Yarima Bako M Mumina A Guindo O Page AL Grais RF
Malaria journal 2019 Dec 26; 18(1); 443. doi: 10.1186/s12936-019-3079-1. Epub 2019 12 26
Histidine-rich protein 2 Malaria Niger Plasmodium lactate dehydrogenase Rapid diagnostic test

Active and adaptive case finding to estimate therapeutic program coverage for severe acute malnutrition: a capture-recapture study.

Abstract

BACKGROUND: Coverage is an important indicator to assess both the performance and effectiveness of public health programs.

Isanaka S Hedt-Gauthier BL Salou H Berthé F Grais RF Allen BGS
BMC health services research 2019 Dec 16; 19(1); 967. doi: 10.1186/s12913-019-4791-9. Epub 2019 12 16
Active and adaptive Capture recapture Case finding Community-based management of acute malnutrition Coverage Nigeria SQUEAC Severe acute malnutrition Therapeutic feeding program

Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression.

Abstract

BACKGROUND: Residual systemic inflammation, which is associated with non-AIDS clinical outcomes, may persist despite viral suppression.

Musinguzi N Castillo-Mancilla J Morrow M Byakwaga H Mawhinney S Burdo TH Boum Y Muzoora C Bwana BM Siedner MJ Martin JN Hunt PW Bangsberg DR Haberer JE
Journal of acquired immune deficiency syndromes (1999) 2019 Dec 01; 82(4); 386-391. doi: 10.1097/QAI.0000000000002148. Epub 2019 11 01

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

Abstract

BACKGROUND: Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial.

Mulangu S Dodd LE Davey RT Tshiani Mbaya O Proschan M Mukadi D Lusakibanza Manzo M Nzolo D Tshomba Oloma A Ibanda A Ali R Coulibaly S Levine AC Grais R Diaz J Lane HC Muyembe-Tamfum JJ Sivahera B Camara M Kojan R Walker R Dighero-Kemp B Cao H Mukumbayi P Mbala-Kingebeni P Ahuka S Albert S Bonnett T Crozier I Duvenhage M Proffitt C Teitelbaum M Moench T Aboulhab J Barrett K Cahill K Cone K Eckes R Hensley L Herpin B Higgs E Ledgerwood J Pierson J Smolskis M Sow Y Tierney J Sivapalasingam S Holman W Gettinger N Vallée D Nordwall J
The New England journal of medicine 2019 Nov 27; doi: 10.1056/NEJMoa1910993. Epub 2019 11 27

Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda

Abstract

INTRODUCTION: Yellow fever is endemic in specific regions of sub-Saharan Africa and the Americas, with recent epidemics occurring on both continents.

Derick Kimathi Aitana Juan Philip Bejon Rebecca F. Grais George M. Warimwe
Wellcome Open Research 2019 Nov 21; 4:182;10.12688/wellcomeopenres.15579.1
Yellow Fever Vaccination